In situ standardised AgNOR analysis: A simplified method for routine use to determine prognosis and chemotherapy efficiency in colorectal adenocarcinoma

Micron

Volumn 31, Issue 2, 2000, Pages 161-164

  Ofner D ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Chemotherapy efficiency; Colorectal neoplasm s therapy; Colorectal neoplasms; Nucleolus organiser region chemistry; Prognosis

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; NUCLEAR PROTEIN;

ADENOCARCINOMA; ARTICLE; CHROMOSOME NOR; COLORECTAL TUMOR; HUMAN; PATHOLOGY; PROGNOSIS; SILVER STAINING;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FLUOROURACIL; HUMANS; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; SILVER STAINING;

EID: 0034174653     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-4328(99)00073-6     Document Type: Article

References (25)

1. Cubick G., Seminow G., Hertle L., Schmid K.W., Öfner D. Standardized AgNOR analysis in radically resected prostate cancer - correlation with PSA values and survival. Cell Anal. Pathol. 16:1998;113-114.
2. Derenzini M., Sirri V., Trerè D., Ochs R.L. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab Invest. 73:1995;497-502.
3. Derenzini M., Trerè D., Pession A., Montanaro L., Sirri V., Ochs R.L. Nucleolar function and size in cancer cells. Am. J. Pathol. 152:1998;1291-1297.
4. Giuffrè G., Barresi G., Speciale G., Gioffre Sarnelli R., Florio M.A., Tuccari G. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes? Eur. J. Histochem. 41:1997;111-118.
5. Heald R.J., Moran B.J., Ryall R.D., Sexton R., MacFarlane J.K. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch. Surg. 133:1998;894-899.
6. Hermanek P. jr, Wiebelt H., Riedl S., Staimmer D., Hermanek P. Long-term results of surgical therapy of colon cancer. Results of the Colorectal Cancer Study Group. Chirurg. 65:1994;287-297.
7. Hermanek P., Wiebelt H., Staimmer D., Riedl S. Prognostic factors of rectum carcinoma - experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori. 81:1995;60-64.
8. Krook J.E., Moertel C.G., Gunderson L.L., Wieand H.S., Collins R.T., Beart R.W., Kubista T.P., Poon M.A., Meyers W.C., Mailliard J.A., Twito D.I., Morton R.F., Veeder M.H., Witzig T.E., Cha S. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N. Engl. J. Med. 324:1991;709-715.
9. Moertel C.G., Fleming T.R., MacDonald J.S., Haller D.G., Laurie J.A., Tangen C.M., Ungerleider J.S., Emerson W.A., Tormey D.C., Glick J.H. Fluorouracil plus levamosile as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann. Int. Med. 122:1995;321-326.
10. O'Connell M.J., Mailliard J.A., Kahn M.J., Macdonald J.S., Haller D.G., Mayer R.J., Wieand H.S. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J. Clin. Oncol. 15:1997;246-250.
11. Öfner D., Schmid K.W. Standardized AgNOR analysis: its usefulness in surgical oncology. Histochem. Cell Biol. 106:1996;193-196.
12. Öfner D., Aubele M., Biesterfeld S., Derenzini M., Giminez-Mas J., Hufnagl P., Ploton D., Trerè D., Rüschoff J. Guidelines of AgNOR quantification - first update. Virchows Arch. 427:1995;341.
13. Öfner D., Bankfalvi A., Riehemann K., Bier B., Böcker W., Schmid K.W. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues. Mod. Pathol. 7:1994;946-950.
14. Öfner D., Bankfalvi A., Riehemann K., Böcker W., Schmid K.W. A standardized AgNOR staining method for formalin fixed and paraffin embedded material. Pathologe. 15:1994;226-230.
15. Öfner D., Bier B., Heinrichs S., Berghorn M., Dünser M., Hagemann H.A., Langer D., Böcker W., Schmid K.W. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival. Breast Cancer Res. Treat. 39:1996;165-176.
16. Öfner D., Hittmair A., Marth C., Öfner C., Totsch M., Daxenbichler G., Mikuz G., Margreiter R., Schmid K.W. Relationship between quantity of silver stained nucleolar organizer regions associated proteins (Ag-NORs) and population doubling time in ten breast cancer cell lines. Pathol. Res. Pract. 188:1992;742-746.
17. Öfner D., Riedmann B., Maier H., Hittmair A., Rumer A., Tötsch M., Spechtenhauser B., Böcker W., Schmid K.W. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma-correlation with tumour stage and long-term survival. J. Pathol. 175:1995;441-448.
18. Öfner D., Weiss H., Sandbichler P., Maier H., Larcher P., Holzberger P., Tötsch M., Schmid K.W. Standardized AgNOR analysis in colorectal adenocarcinoma: correlation with chemotherapy efficacy. Cancer Detect. Prev. 20:1996;473-474.
19. Piffko J., Bankfalvi A., Öfner D., Rasch D., Joos U., Schmid K.W. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas. J. Pathol. 182:1997;450-456.
20. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., Adnet J.J. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem. J. 18:1986;5-14.
21. Riedmann B., Maier H., Weiss H., Schwab G., Labeck B., Tötsch M., Schmid K., Öfner D. Silver stained nucleolar organizer regions associated protein (AgNOR) analysis: a major prognostic factor in gastric carcinoma. Tumordiagn. Ther. 19:1998;35-41.
22. Stewart J.M., Zalcberg J.R. Update on adjuvant treatment of colorectal cancer. Curr. Opin. Oncol. 10:1998;367-374.
23. Tötsch M., Öfner D., Maier H., Watzka S.B.C., Salzer M., Schmid K.W. Argyrophilic nucleolar organizer region associated proteins (AgNORs) in adenocarcinomas and squamous cell carcinomas of the lung - correlation with tumour stage and long-term survival. Pathol. Res. Pract. 191:1995;800.
24. Trerè D., Gramantieri L., Siringo S., Melchiorri C., Barbara L., Bolondi L., Derenzini M. In hepatocellular carcinoma AgNOR protein expression correlates with tumour mass doubling time. J. Hepatol. 24:1996;60-65.
25. Trerè D., Pession A., Derenzini M. The silver-stained proteins of interphasic nucleolar organizer regions as a parameter of cell duplication rate. Exp. Cell Res. 184:1989;131-137.